Company: Biovotec AS, Norway (Project Coordinator)

Partners: Cica Biomedical Ltd, UK and University Côte d’Azur, France

Project Name: Deepcure (No:12852)

Project duration: 2 years from 1 April 2019.

 

Biovotec and its partners have been awarded an R&D grant under the EU Eurostars program. The goal of this project, called Deepcure, is the development of a novel and affordable 3D biomaterial based on Purified Eggshell membrane Protein (PEP) for deep wounds and burns.

 

Today, many hospitals cannot afford to use the currently available advanced tissue engineering-based solutions for treating these wounds due to cost considerations. Based on their relatively high perceived cost, there are difficulties in establishing clear cost/benefit conclusions in the treatment of trauma wounds which vary widely in their presentation. Therefore, there is an urgent need for a product that would significantly reduce treatment costs while delivering equivalent outcomes to current tissue engineering based products.

 

Based on our experience in developing DermaRep™, also based on PEP technology, Biovotec is now developing and optimizing 3D biomaterials which we expect will be available for clinical evaluation at the end of the project period.

Engebrets vei 3, 0275 Oslo, Norway                                                   © Biovotec AS                                                                       info@biovotec